Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Dansk Sundhedsteam ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.8% 0.8%   Bankruptcy risk   6.4% 4.1% 4.6% 2.5% 1.7% 1.3% 10.0% 10.0%   Credit score (0-100)   38 50 46 61 73 79 25 25   Credit rating   BBB BBB BBB BBB A A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 3.0 39.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   399 354 383 1,353 2,083 2,389 0.0 0.0   EBITDA   215 144 92.0 259 660 557 0.0 0.0   EBIT   211 139 87.6 259 660 529 0.0 0.0   Pre-tax profit (PTP)   207.7 136.4 85.4 251.5 652.7 528.8 0.0 0.0   Net earnings   162.0 105.1 65.4 195.3 508.0 412.1 0.0 0.0   Pre-tax profit without non-rec. items   208 136 85.4 251 653 529 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   8.7 4.4 0.0 0.0 0.0 252 0.0 0.0   Shareholders equity total   220 325 391 586 1,094 1,506 1,456 1,456   Interest-bearing liabilities   0.3 43.4 94.8 0.0 119 247 0.0 0.0   Balance sheet total (assets)   578 563 527 948 1,665 2,201 1,456 1,456   Net Debt   -467 -269 -78.4 -427 -1,228 -1,170 -1,456 -1,456     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   399 354 383 1,353 2,083 2,389 0.0 0.0   Gross profit growth   144.3% -11.3% 8.4% 253.1% 53.9% 14.7% -100.0% 0.0%   Employees   1 1 1 1 2 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 100.0% 50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   578 563 527 948 1,665 2,201 1,456 1,456   Balance sheet change%   133.4% -2.7% -6.3% 79.6% 75.7% 32.2% -33.8% 0.0%   Added value   215.4 143.6 92.0 258.6 660.4 556.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -9 -9 -9 0 0 224 -252 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   52.9% 39.4% 22.9% 19.1% 31.7% 22.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   51.1% 24.4% 16.2% 35.1% 50.6% 27.4% 0.0% 0.0%   ROI %   103.6% 47.3% 20.7% 48.3% 73.4% 35.6% 0.0% 0.0%   ROE %   116.6% 38.6% 18.3% 40.0% 60.5% 31.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   38.1% 57.8% 74.1% 61.8% 65.7% 68.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -216.6% -187.1% -85.3% -165.1% -186.0% -210.2% 0.0% 0.0%   Gearing %   0.2% 13.4% 24.3% 0.0% 10.9% 16.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.1% 12.7% 4.1% 15.8% 13.3% 0.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.6 2.3 3.7 2.4 2.8 2.7 0.0 0.0   Current Ratio   1.6 2.3 3.7 2.4 2.8 2.7 0.0 0.0   Cash and cash equivalent   466.9 312.1 173.3 426.8 1,347.7 1,417.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   211.3 305.4 375.2 510.8 1,018.8 1,181.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   215 144 92 259 330 186 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   215 144 92 259 330 186 0 0   EBIT / employee   211 139 88 259 330 176 0 0   Net earnings / employee   162 105 65 195 254 137 0 0